A process for the preparation of plexifilamentary film-fibril strands of polymer. The process includes the steps of generating a spin fluid containing (a) 5 to 30 wt. % containing one or more polymer types, (b) a primary spin agent selected from the group consisting of dichloromethane, cis-1,2-dichloroethylene and trans-1,2-dichloroethylene, and (c) a co-spin agent comprising 1H,6H-perfluorohexane or 1H-perfluorohexane or 1H-perfluoroheptane. The spin fluid is flash-spun at a pressure that is greater than the autogenous pressure of the spin fluid into a region of lower pressure to form plexifilamentary film-fibril strands of the polymer. The co-spin agent is present in the spin fluid in an amount sufficient to form an azeotrope-like composition with the primary spin agent in the presence of the one or more polymer types. The polymer may be selected from the group consisting of high density polyethylene, polypropylene, polybutene-1, polymethylpentene, polyvinylidene fluoride, poly (ethylene tetrafluoroethylene), and blends of the foregoing.

An actuator device and method of manufacturing the same that includes at least two or more panels disposed in a frame is disclosed. Each of the two or more panels include a first rotationally-actuating artificial muscle fiber section between a first contact point of the frame and a tether point located on the panel and a second rotationally-actuating artificial muscle fiber section between the tether point and a second contact point on the frame. The tether point is approximately halfway across the length of the panel. A first and second muscle support is disposed on the panel between the tether point and the first contact point. The actuator device also includes a synchronization rod attached to the at least two or more panels.

An actuator device and method of manufacturing the same that includes at least two or more panels disposed in a frame is disclosed. Each of the two or more panels include a first rotationally-actuating artificial muscle fiber section between a first contact point of the frame and a tether point located on the panel and a second rotationally-actuating artificial muscle fiber section between the tether point and a second contact point on the frame. The tether point is approximately halfway across the length of the panel. A first and second muscle support is disposed on the panel between the tether point and the first contact point. The actuator device also includes a synchronization rod attached to the at least two or more panels.

A medical appliance or prosthesis may comprise one or more layers of rotational spun nanofibers, including rotational spun polymers. The rotational spun material may comprise layers including layers of polytetrafluoroethylene (PTFE). Rotational spun nanofiber mats of certain porosities may permit tissue ingrowth into or attachment to the prosthesis. Additionally, one or more cuffs may be configured to allow tissue ingrowth to anchor the prosthesis.

A medical appliance or prosthesis may comprise one or more layers of rotational spun nanofibers, including rotational spun polymers. The rotational spun material may comprise layers including layers of polytetrafluoroethylene (PTFE). Rotational spun nanofiber mats of certain porosities may permit tissue ingrowth into or attachment to the prosthesis. Additionally, one or more cuffs may be configured to allow tissue ingrowth to anchor the prosthesis.

Self-adaptive systems, uses of the systems, and methods for adapting one or more properties of a material are disclosed.

Self-adaptive systems, uses of the systems, and methods for adapting one or more properties of a material are disclosed.

Mechanically and piezoelectrically anisotropic polymer fibers may be formed by spinning a polymer solution or gel that includes a high molecular weight crystallizable polymer and a liquid solvent. The solvent may be configured to interact with the polymer to facilitate chain alignment and, in some examples, create a higher crystalline content within the spun fibers. The polymer solution may also include a low molecular weight additive. The high and low molecular weight polymers may each be characterized by a bimodal molecular weight distribution where the molecular weight of the additive is less than the molecular weight of the crystallizable polymer. The polymer(s) and the additive(s) may be independently selected from vinylidene fluoride, trifluoroethylene, chlorotrifluoroethylene, hexafluoropropene, vinyl fluoride, etc. The spun fibers may be oriented, annealed, poled, and woven or laminated to form a polymer thin film having a high elastic modulus and a high electromechanical coupling factor.

A medical appliance or prosthesis may comprise one or more layers of electrospun nanofibers, including electrospun polymers. The electrospun material may comprise layers including layers of polytetrafluoroethylene (PTFE). Electrospun nanofiber mats of certain porosities may permit tissue ingrowth into or attachment to the prosthesis.

A medical appliance or prosthesis may comprise one or more layers of electrospun nanofibers, including electrospun polymers. The electrospun material may comprise layers including layers of polytetrafluoroethylene (PTFE). Electrospun nanofiber mats of certain porosities may permit tissue ingrowth into or attachment to the prosthesis.